Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Continue reading
Today, Leavitt Partners announced the acquisition of Torch Insight® by Milliman, Inc. This acquisition will combine Torch Insight’s powerful market-centered data and analytics with MedInsight, Milliman’s flagship healthcare analytics ecosystem. Torch Insight brings Milliman decades of healthcare policy expertise and healthcare analytic experience backed by Leavitt Partners – recognized experts in the health sector. The … Continue reading
On June 23, 2020, Governor Michael O. Leavitt, former United States Secretary of Health and Human Services testified before the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) in a hearing titled, “COVID-19: Lessons Learned to Prepare for the Next Pandemic.” HELP Committee Chairman Lamar Alexander (R-TN) released a white paper titled “Preparing … Continue reading
Tomorrow, Governor Michael O. Leavitt, former U.S. Secretary for Health and Human Services (HHS), will testify before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP). The hearing is titled “COVID-19: Lessons Learned to Prepare for the Next Pandemic.” Governor Leavitt will share insights from his time as HHS Secretary, where he worked … Continue reading
Today, Leavitt Partners released “COVID-19 Hotspots,” a white paper that informs policymakers, industry leaders, and other key stakeholders to quickly assess where to deploy resources during the ongoing pandemic, and the accompanying, free tool that provides a daily updated map of where COVID-19 hotspots are forming in the United States. The authors discuss the nuances … Continue reading
Today, Leavitt Partners released “Understanding the Coronavirus & Situational Characteristics: A Framework for Individuals and Businesses for Mitigating Risk,” a white paper informed by contagion principles of the virus that provides opportunities for creative interventions. The paper walks through virus transmission and key principles for reducing spread, as well as assessing situational characteristics to mitigate … Continue reading
Today, the American Journal of Managed Care (AJMC) released an article entitled “Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems.” This article outlines the shift in accountable care organization (ACO) market leadership as physician group organizations have begun to lead the majority of new ACOs. Data on ACO provider types … Continue reading
New analysis from Leavitt Partners and CareJourney explores ways in which accountable care organizations (ACOs) can reduce health care costs without potentially impacting their beneficiaries’ quality of care. One such opportunity for ACOs lies in switching patients to similarly effective but less-expensive medications for particular conditions. Our analysis of Medicare claims data from 2014 to … Continue reading
As the U.S. begins to re-open on a localized level from precautions taken during this pandemic, forward-looking data is vital to our recovery. A continuously monitored short-term outlook on where the next potential outbreak may occur is critical for successful strategic response. Businesses, health care organizations, and public officials should constantly adjust their strategies and … Continue reading
Today, Leavitt Partners Insight (LPI), provider of Torch Insight™, launched the COVID-19 Burden Index to aid U.S. health care providers and public health officials in tracking and measuring the burden of the COVID-19 pandemic. The tool estimates, in near-real-time, the percent of normal hospital and intensive care unit (ICU) bed capacity currently in use by … Continue reading
